Ambu A/S (OTCMKTS:AMBBY) Sees Unusually-High Trading Volume – Still a Buy?

Shares of Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) saw strong trading volume on Friday . 500 shares changed hands during mid-day trading, a decline of 29% from the previous session’s volume of 708 shares.The stock last traded at $11.00 and had previously closed at $10.20.

Ambu A/S Price Performance

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.67 and a current ratio of 2.86. The company’s 50 day moving average price is $11.49 and its 200-day moving average price is $13.29. The company has a market cap of $2.58 billion, a price-to-earnings ratio of 35.48 and a beta of 1.25.

Ambu A/S (OTCMKTS:AMBBY) last issued its earnings results on Wednesday, February 4th. The company reported $0.07 earnings per share for the quarter. The firm had revenue of $242.85 million during the quarter. Ambu A/S had a net margin of 8.86% and a return on equity of 9.15%.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.